Centiva Capital’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,428
Closed -$210K 1952
2025
Q2
$210K Sell
8,428
-2,257
-21% -$63.6K ﹤0.01% 1323
2025
Q1
$331K Sell
10,685
-559
-5% -$18.6K 0.01% 1028
2024
Q4
$355K Buy
+11,244
New +$534K 0.01% 1040
2024
Q1
Sell
-5,914
Closed -$227K 2342
2023
Q4
$227K Buy
+5,914
New +$197K 0.01% 1358
2023
Q2
Sell
-6,361
Closed -$232K 2071
2023
Q1
$232K Buy
+6,361
New +$223K 0.01% 1165

Other funds holding ASTH

Centiva Capital's ASTH Position: Q3 2025 in Review

Centiva Capital sold out of Astrana Health (ASTH) in Q3 2025, closing a stake of 8,428 shares — an estimated $210K sold.

Centiva Capital first reported a position in ASTH in Q1 2023 and held it in 5 quarters. The position peaked at $355K in Q4 2024. 188 funds tracked by Wall St. Rank hold ASTH as of Q3 2025.

  • Centiva Capital reported no remaining Astrana Health position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 8,428 Astrana Health shares in Q3 2025, an estimated $210K.
  • Centiva Capital first reported a position in Astrana Health in Q1 2023 and held it in 5 quarters.
  • Centiva Capital's Astrana Health position peaked at $355K in Q4 2024.
  • 188 funds tracked by Wall St. Rank held Astrana Health as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.